Earnings History Data for iBio, Inc. (IBIO) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

iBio, Inc.

Ibio Inc., formerly known as iBioPharma Inc., is a biopharmaceutical company that primarily focuses on developing vaccines and therapeutic proteins based upon its plant-based iBioLaunch platform technology. The Company's hydroponically grown green plants can be used for the development and manufacture of proteins applicable to a range of disease agents, such as influenza, sleeping sickness, anthrax, plague, human papillomavirus and veterinary influenza applications. IBio, Inc. is headquartered in Newark, Delaware.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
12-05-2022	AH	4:05 PM ET (May 12)	IBIO	iBio, Inc.	58.90	-0.06	0.00	-0.04	iBio GAAP EPS of -$0.06 in-line, revenue of $1.94M beats by $1.74M [5/12/2022 4:07 PM]	0.2571	-0.01 (-4.74%)	0.25	-0.02 (-7.74%)	0.24 - 1.75	2,307,871	1,820,000	52,099
iBio GAAP EPS of -$0.06 in-line, revenue of $1.94M beats by $1.74M [5/12/2022 4:07 PM] iBio quarterly net loss widens 61% even as revenue shows strong gain [5/13/2022 12:55 PM] iBio Reports Fiscal Third Quarter 2022 Financial Results and Provides Corporate Update [May-12-22 04:05PM]
14-02-2022	AH	4:05 PM ET (Feb 14)	IBIO	iBio, Inc.	85.00	-0.05	0.00	-0.04	iBio GAAP EPS of -$0.05 misses by $0.01, revenue of $0.17M misses by $0.08M [2/14/2022 4:09 PM]	0.3781	-0.01 (-3.15%)	0.38	-0.02 (-3.94%)	0.36 - 2.50	3,356,906	2,560,000	120,553
iBio GAAP EPS of -$0.05 misses by $0.01, revenue of $0.17M misses by $0.08M [2/14/2022 4:09 PM] iBio Reports Fiscal Second Quarter 2022 Financial Results and Provides Corporate Update [Feb-14-22 04:05PM]
15-11-2021	AH	4:05 PM ET (Nov 15)	IBIO	iBio, Inc.	168.61	-0.04	0.00	-0.05	iBio misses on revenue [11/15/2021 4:17 PM]	0.6917	-0.06 (-7.77%)	0.73	-0.02 (-2.60%)	0.69 - 2.83	4,567,866	4,630,000	74,677
iBio misses on revenue [11/15/2021 4:17 PM] iBio Announces Collaboration with UT Southwestern to Investigate IBIO-100 in Solid Tumors [Nov-15-21 01:00PM] iBio Reports Fiscal First Quarter 2022 Financial Results and Provides Corporate Update [Nov-15-21 04:05PM]
27-09-2021	PM	7:00 AM ET (Sep 27)	IBIO	iBio, Inc.	254.88	-0.05	0.00	0.00	iBio misses on revenue; issues guidance [9/27/2021 7:36 AM]	1.14	-0.03 (-2.57%)	1.13	-0.04 (-3.42%)	1.03 - 2.83	3,919,594	2,390,000	499,218
iBio misses on revenue; sees sequential decline in revenue during 1H22 vs. 2H21 [9/27/2021 7:36 AM] iBio Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Corporate Update [Sep-27-21 07:30AM]
17-05-2021	PM	0:00 AM ET (May 17)	IBIO	iBio, Inc.	321.85	-0.04	0.00	-0.06	iBio revenue in-line [5/17/2021 7:04 AM]	1.36	-0.11 (-7.48%)	1.40	-0.07 (-4.76%)	1.03 - 7.45	9,234,978	41,930,000	1,102,217
iBio revenue in-line [5/17/2021 7:04 AM] iBio Q1 net loss widens as expenses soar year-over-year; shares fall 6% [5/17/2021 10:08 AM] iBio, Inc. to Host Earnings Call [May-17-21 06:15AM] iBio Reports Fiscal Third Quarter 2021 Financial Results and Provides Corporate Update [May-17-21 07:00AM]
16-02-2021	AH		IBIO	iBio, Inc.	505.46	-0.04	0.00	-0.69	iBio beats on revenue [2/16/2021 4:07 PM]	2.06	-0.27 (-11.59%)	2.06	-0.27 (-11.59%)	0.27 - 7.45	22,158,324	27,545,788	1,589,964
iBio beats on revenue [2/16/2021 4:07 PM] Despite narrower fiscal Q2 2021 loss, iBio expenses grow; shares fall after hours [2/16/2021 4:54 PM] iBio Reports Fiscal Second Quarter 2021 Financial Results and Provides Corporate Update [Feb-16-21 04:05PM] iBio, Inc. to Host Earnings Call [Feb-16-21 02:30PM] iBio Appoints Robert M. Lutz as Chief Financial & Business Officer [Feb-16-21 08:00AM]
16-11-2020	AH	Before the open (Nov 16)	IBIO	iBio, Inc.	310.09	-0.05	0.00	-0.21	iBio EPS beats by $0.03, beats on revenue [11/16/2020 4:09 PM]	1.70	-0.35 (-17.07%)	1.66	-0.39 (-19.02%)	0.05 - 7.45	13,100,195	7,145,613	1,596,872